Return to the Faculty List
Dan W. Haupt, MD
Current
Position
Assistant Professor of Psychiatry
University Roles
Director, Consultation-Liaison Psychiatry, Barnes-Jewish Hospital
Medical Director, Psychosocial Oncology, Siteman Cancer Center
Education and Training
B.S.: Lewis & Clark College, Portland, Oregon, 1991
Medical Degree: University of Vermont College of Medicine, Burlington, Vermont, 1997
Residency: Psychiatry, Washington University School of Medicine, St. Louis, Missouri, 2001
Major Awards
2008 Washington University Department of Psychiatry Excellence in Teaching Award
2007 Sidney R. Baer Investigator, NARSAD Research Partners Program
2006 Collegium Internationale Neuro-Psychopharmocologicum Young Investigator Travel Awardee
2004 American College of Neuropsychopharmacology Young Investigator Travel Awardee
2003 Recipient of Society of Biological Psychiatry Scholarship Program Award
2002 Lieber Investigator, NARSAD Research Partners Program
Washington University Department of Psychiatry Eli Robins Award, for Excellence in Clinical Psychiatry, In Teaching and In Research, 2000
University of Vermont College of Medicine Neuroscience Research Award, 1997
University of Vermont Medical Alumni Prize for Undergraduate Research in Clinical Science, 1997
Areas of Clinical Interest
Schizophrenia, psychotic disorders, general psychiatry, depression, mood disorders, bipolar affective disorder
Active research program benefiting schizophrenia patients now available.
Topics of study include effects of atypical antipsychotic medications on blood sugar levels and weight gain.
Areas of Research Interests
Impairments in weight regulation, and glucose and lipid metabolism associated with mental illness and its treatment.
Metabolic studies of glucose and lipid metabolism in schizophrenia and bipolar patients.
Metabolic studies of effects of polypharmacy.
Key Publications
Haupt DW, Rosenblatt LC, Kim E, Ross A Baker RA, Whitehead R, Newcomer JW. Prevalence and Predictors of Lipid and Glucose Monitoring among Commercially Insured Patients Treated with Second-Generation Antipsychotic Agents. Am J Psychiatry. 2009 Mar;166(3):345-53.
Haupt DW, Luber A, Maeda J, Melson AK, Schweiger J, Newcomer JW. The relationship between plasma leptin levels and adiposity during antipsychotic treatment of schizophrenia. Neuropsychopharmacology. 2005;30:184-91
Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindenmayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry. 2004;65:4-18.
Haupt DW, Newcomer JW: Abnormalities in glucose regulation associated with mental illness and treatment. J Psychosomatic Research . 2002;53(4):925-933.
Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper B, Selke G: Abnormalities in glucose regulation during antipsychotic treatment in schizophrenia Arch Gen Psychiatry 2002 59:337-345.
Haupt DW, Newcomer JW: Hyperglycemia and antipsychotic medications J Clin Psych 2001 62: Supplement 27 15-26.